Navigation Links
ClearTrial Names Proven Enterprise Software and Life Sciences Sales Leader Craig Smith as Vice President of Sales

With 25 years of experience in enterprise software and technology markets including the life sciences, oil and gas, and chemical industries, Smith provides a successful track record of building and managing high-performing sales teams and implementing repeatable sales methodologies that consistently exceed revenue targets.

Chicago, IL (PRWEB) October 13, 2009 -- ClearTrial (, the leading provider of Clinical Trial Operations (CTO) software for integrated planning, forecasting, outsourcing, and project tracking, announced today that enterprise software and life sciences sales veteran Craig D. Smith has joined the company as Vice President of Sales. With 25 years of experience in enterprise software and technology markets including the life sciences, oil and gas, and chemical industries, Smith provides a successful track record of building and managing high-performing sales teams and implementing repeatable sales methodologies that consistently exceed revenue targets.

As Vice President of Sales, Smith will be responsible for ensuring that ClearTrial's worldwide sales and services organization meets the rapidly increasing market demand for the company's award-winning software, and for providing strategic insight into market expansion and the establishment of new markets. He will oversee the development of the enterprise sales and clinical services team and assist in driving the company's go-to-market strategy for the life sciences industry.

"Craig Smith has an impressive track record for enterprise software sales in life sciences and other industries with complex, business-driven sales cycles," noted ClearTrial CEO Mike Soenen. "His extensive experience and results-oriented managerial approach will help us expand our global presence and further our reputation for helping life science companies streamline their clinical operations from plan to cash."

Smith's career demonstrates a consistent pattern of sales growth and leadership, with all of his sales teams establishing company records. At Documentum (now EMC), Smith was instrumental in building and leading the pharmaceutical industry vertical. During his tenure, Documentum became the pharmaceutical industry leader by providing high-value business applications that accelerated key business processes, responsive relationships with customers, and valued partner relationships. His sales and pre-sales organization consistently exceeded goals and grew revenue over tenfold in just four years by focusing on operational execution that placed the customer's requirements first.

At Saba Software, Smith built an enterprise sales team and grew North American sales eightfold to over $50M in two years through collaborative efforts with Saba customers and partners. During his tenure, Saba established the beginning of the enterprise-wide human capital management software market. As vice president of enterprise sales at iManage (Interwoven), Smith drove sales of the company's industry-leading collaboration products to enterprise customers.

"ClearTrial clinical trial operations software is a unique offering with real business value for an industry seeking ways to gain superior performance from their clinical operations," observed Smith. "ClearTrial has been embraced by customers for delivering greater efficiency while reducing costs, and providing senior executives with fast, accurate, and consistent visibility to their business. I'm looking forward to helping ClearTrial further improve its well-earned growth trajectory."

About ClearTrial®
ClearTrial is the leading provider of Clinical Trial Operations (CTO) software, a seamlessly integrated system for clinical operations planning, forecasting, outsourcing, and project tracking. ClearTrial's award-winning software helps life sciences companies streamline their clinical operations from Plan to Cash™ without sacrificing quality of results, providing executives and functional leaders in clinical operations, resource planning, finance, outsourcing, and project management with a common platform that promotes speed, accuracy, and consistency throughout the organization. For more information please visit

ClearTrial® and the ClearTrial logo are registered trademarks, and Plan to Cash™ is a trademark, owned by ClearTrial, LLC, which may be registered in certain jurisdictions. Any other company or product names mentioned in this release are hereby acknowledged as registered trademarks or trademarks of their respective owners.

For more information contact:

Mike Lange
+1 630.986.9800 x112


Read the full story at

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved

Related biology technology :

1. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
2. ClearTrial Launches Version 2.7 of its Clinical Trial Operations Planning Software Featuring Advanced Portfolio Planning Capability
3. ClearTrial Names Software Industry Veteran Michael Bruns as Chief Operating Officer
4. ClearTrial to Chair Session at DIA 45th Annual Meeting on "Effective Operational Planning for Adaptive Clinical Trials"
5. ClearTrial Industry Expert to Lead Session at DIA Annual Meeting on Improving Accrual and Contract Management in Clinical Trials
6. ClearTrial Selected to Lead Executive Panel from Pharmaceutical and Service Provider Companies at ExL Conference
7. ClearTrial Launches Industry-first Software Platform for Integrating Clinical Trial Operations from Plan to Cash™, Driving Operational Efficiencies and Accelerating Clinical Development
8. KGI Names Kerry Howell Vice President for Advancement
9. Vical Names Andrew de Guttadauro Vice President, Corporate Development
10. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
11. Magellan Biosciences Names Steven E. Diamond, PhD, Chief Scientific Officer
Post Your Comments:
(Date:10/13/2015)... and SAN DIEGO , Oct. ... Therapeutics, Inc. have agreed to collaborate in the development ... 188 NF, marketed by BASF under the Kolliphor ® ... variety of pharmaceutical and biological applications, such as a ... the starting material for Mast,s lead product candidate. Under ...
(Date:10/13/2015)... ... October 13, 2015 , ... Exotic ... material handling solutions and components, is opening its latest Parker Store retail location ... facility is Exotic’s second major expansion in Metropolitan Detroit in less than a ...
(Date:10/13/2015)... LONDON , October 13, 2015 ... Europe .  PRCC represents about 14% of all ... United States , Canada and ... cases of kidney cancer.   --> Hutchison China MediTech ... its drug R&D subsidiary, and AstraZeneca AB (publ) ("AstraZeneca") have completed ...
(Date:10/12/2015)... Oct. 12, 2015  Rebiotix Inc. today announced ... designated its lead Microbiota Restoration Therapy (MRT) RBX2660 ... recurrent Clostridium difficile (C diff) infection, ... causes 29,000 deaths in the U.S. annually. 1 ... that was founded to revolutionize the treatment of ...
Breaking Biology Technology:
(Date:10/7/2015)... , October 8, 2015 --> ... for Fingerprint Cards (FPC) during third quarter 2015 amounted to ... of around 860 MSEK that was communicated 20 August 2015. ... further strengthened delivery capacity and a continued growing demand for ... is estimated to be higher than during the third quarter. ...
(Date:10/6/2015)... SAN MATEO, Calif. , Oct. 6, 2015 ... software company, today announced enhancements to its software ... gene expression analysis kit for differential expression in ... Analytic Platform, which is a cloud-based genomic analysis ... to advance scientific discovery from next-generation sequencing efforts. ...
(Date:10/1/2015)... , Oct. 1, 2015  Biometrics includes ... analysing human body characteristics, such as fingerprints, eye ... purposes. Adoption of biometrics technology has been constantly ... the last five years. In addition to the ... is fingerprint recognition, other means of biometric authentication ...
Breaking Biology News(10 mins):